Diabetes Clinical Trials in Nashville

Showing 341-360 of 613 trials

Characteristics of Glargine in Type 2 Diabetics

NCT00574912

The study is to determine the dose response relationship of insulin glargine in type 2 diabetes over a 24-hour period and measuring the differences in glucose production among the differing doses of glargine. Hypothesis: Differing doses of insulin glargine over a 24-hour period in type 2 diabetes will show differing effects on endogenous glucose production, glucose disposal and carbohydrate and lipid flux.

Type 2 Diabetes

Vanderbilt University Medical Center20 participantsStarted Mar 2007

Nashville, Tennessee, United States

COMPLETEDNA< 1 mile

Aldosterone and Glucose Homeostasis

NCT00732160

Determine the effect of aldosterone on how the body handles glucose (sugar).

Diabetes Mellitus

Vanderbilt University34 participantsStarted Sep 2008

Nashville, Tennessee, United States

COMPLETEDPhase 3< 1 mile

A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin

NCT01570751

This trial is conducted in the United States of America (USA). The aim of the trial is to confirm the efficacy of IDeg (insulin degludec) versus IGlar (insulin glargine) in controlling glycaemia. Subjects are to continue their pre-trial metformin treatment.

DiabetesDiabetes Mellitus, Type 2

Novo Nordisk A/S145 participantsStarted Apr 2012

Mesa, Arizona, United States • Fresno, California, United States • Greenbrae, California, United States +43 more locations

Characteristics of Glargine in Type 2 Diabetics

Aldosterone and Glucose Homeostasis

A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin

Diabetes Trials in Other Cities

Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin

Comparison of Two Insulin Degludec Formulations in Subjects With Type 2 Diabetes Mellitus

The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes

Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes

Comparing the Efficacy and Safety of NN1250 Once Daily When Titrated Using 2 Different Algorithms in Insulin naïve Subjects With Type 2 Diabetes Mellitus

A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naïve Subjects With Type 2 Diabetes

Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes

The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes

Study In People With Type 2 Diabetes

The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus

Thiazolidinedione Intervention With Vitamin D Evaluation

Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes

BD FlowSmart™ Subcutaneous Insulin Infusion Set User Preference and Claims Study

Comparison of NN5401 With Insulin Glargine, Both in Combination With Oral Antidiabetic Drugs, in Subjects With Type 2 Diabetes

Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes

A Study of LY2405319 in Participants With Type 2 Diabetes

Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary Disease

Other Conditions in Nashville